 WES MOORE, Governor  Ch. 39  
 
– 1 – Chapter 39  
(House Bill 279 ) 
 
AN ACT concerning  
 
Prescription Drug Affordability Board – Upper Payment Limits  
 
FOR the purpose of reestablishing the requir ement that  the Prescription Drug Affordability 
Board , under certain circumstances,  draft a plan of action for implementing a process 
to set upper payment limits for prescription drug products that it determines have 
led or will lead to affordability challenges;  reestablishing the authority of the Board 
to set upper payment limits , under certain circumstances,  for prescription drug 
products that are purchased or paid for by or through certain State or local 
government entities, plans, or programs ; reestablishing a  certain appeals process for 
persons aggrieved by an upper payment limit set by the Board; reestablishing the 
requir ement that  the Board submit a report to certain committees of the General 
Assembly recommending whether the General Assembly should expand t he Board’s 
authority to set upper payment limits to all purchases and payor reimbursements o f 
prescription drug products in the State; and generally relating to the setting of upper 
payment limits by  the Prescription Drug Affordability Board.   
 
BY adding  to 
 Article – Health – General  
Section 21 –2C–13 through 21 –2C–16 
 Annotated Code of Maryland  
 (2019 Replacement Volume and 2022 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article  – Health – General  
 
21–2C–13. 
 
 (A) IF, UNDER § 21–2C–07 OF THIS SUBTITLE , THE BOARD FINDS THAT IT I S 
IN THE BEST INTEREST  OF THE STATE TO ESTABLISH A PROCESS FOR SETTING 
UPPER PAYMENT LIMITS  FOR PRESCRIPTION DRU G PRODUCTS THAT IT 
DETERMINES HAVE LED OR W ILL LEAD TO AN AFFOR DABILITY CHALLENGE , THE 
BOARD , IN CONJUNCTION WITH THE STAKEHOLDER COUNCIL , SHALL DRAFT A PLAN 
OF ACTION FOR IMPLEM ENTING THE PROCESS T HAT INCLUDES THE CRI TERIA THE 
BOARD SHALL USE TO SE T UPPER PAYMENT LIMI TS. 
 
 (B) THE CRITERIA FOR SET TING UPPER PAYMENT L IMITS SHALL INCLUDE 
CONSIDERATION OF : 
 
Ch. 39  2023 LAWS OF MARYLAND   
 
– 2 –   (1) THE COST OF ADMINISTE RING THE PRESCRIPTIO N DRUG 
PRODUCT ; 
 
  (2) THE COST OF DELIVERIN G THE PRESCRIPTION D RUG PRODUCT 
TO CONSUMERS ; AND 
 
  (3) OTHER RELEVANT ADMINI STRATIVE COSTS RELAT ED TO TH E 
PRESCRIPTION DRUG PR ODUCT . 
 
 (C) THE PROCESS FOR SETTI NG UPPER PAYMENT LIM ITS SHALL : 
 
  (1) PROHIBIT THE APPLICAT ION OF AN UPPER PAYM ENT LIMIT FOR A 
PRESCRIPTION DRUG PR ODUCT THAT IS ON THE  FEDERAL FOOD AND DRUG 
ADMINISTRATION PRESCR IPTION DRUG SHORTAGE  LIST; AND 
 
  (2) REQUIRE THE BOARD TO : 
 
   (I) MONITOR THE AVAILABIL ITY OF ANY PRESCRIPT ION DRUG 
PRODUCT FOR WHICH IT  SETS AN UPPER PAYMEN T LIMIT ; AND 
 
   (II) IF THERE BECOMES A SH ORTAGE OF THE PRESCR IPTION 
DRUG PRODUCT IN THE STATE , RECONSIDER OR SUSPEN D THE UPPER PAYMENT 
LIMIT . 
 
 (D) (1) IF A PLAN OF ACTION I S DRAFTED UNDER SUBS ECTION (A) OF THIS 
SECTION , THE BOARD SHALL SUBMIT TH E PLAN OF ACTION TO THE LEGISLATIVE 
POLICY COMMITTEE OF THE GENERAL ASSEMBLY , IN ACCORDANCE WITH § 2–1257  
OF THE STATE GOVERNM ENT ARTICLE , FOR ITS APPROVAL . 
 
  (2) THE LEGISLATIVE POLICY COMMITTEE SHALL HAVE 45 DAYS TO 
APPROVE THE PLAN OF ACTION . 
 
  (3) IF THE LEGISLATIVE POLICY COMMITTEE DOES NOT AP PROVE 
THE PLAN OF ACTION , THE BOARD SHALL SUBMIT TH E PLAN TO THE GOVERNOR AND 
THE  ATTORNEY GENERAL FOR APPROVAL . 
 
  (4) THE GOVERNOR AND THE ATTORNEY GENERAL SHALL HAVE 45 
DAYS TO APPROVE THE PLAN OF ACTION . 
 
  (5) THE BOARD MAY NOT SET UPP ER PAYMENT LIMITS UN LESS THE 
PLAN IS APPROVED , IN ACCORDANCE WITH T HIS SUBSECTION , BY: 
 
 WES MOORE, Governor  Ch. 39  
 
– 3 –    (I) THE LEGISLATIVE POLICY COMMITTEE ; OR 
 
   (II) 1. THE GOVERNOR ; AND 
 
    2. THE ATTORNEY GENERAL . 
 
21–2C–14. 
 
 (A) IF A PLAN OF ACTION I S APPROVED UNDER § 21–2C–13(D) OF THIS 
SUBTITLE , THE BOARD MAY SET UPPER P AYMENT LIMITS FOR PR ESCRIPTION DRUG 
PRODUCTS THAT  ARE: 
 
  (1) PURCHASED OR PAID FOR  BY A UNIT OF STATE OR LOCAL 
GOVERNMENT OR AN ORG ANIZATION ON BEHALF OF A UNIT OF STATE OR LOCAL 
GOVERNMENT , INCLUDING : 
 
   (I) STATE OR COUNTY CORRE CTIONAL FACILITIES ; 
 
   (II) STATE HOSPITALS ; AND 
 
   (III) HEALTH CLINICS AT STATE INSTITUTIONS OF  HIGHER 
EDUCATION ; 
 
  (2) PAID FOR THROUGH A HE ALTH BENEFIT PLAN ON  BEHALF OF A 
UNIT OF STATE OR LOCAL GOVERN MENT , INCLUDING A COUNTY , BICOUNTY , OR 
MUNICIPAL EMPLOYEE H EALTH BENEFIT PLAN ; OR 
 
  (3) PURCHASED FOR OR PAID  FOR BY THE MARYLAND STATE 
MEDICAL ASSISTANCE PROGRAM . 
 
 (B) THE UPPER PAYMENT LIM ITS SET UNDER SUBSEC TION (A) OF THIS 
SECTION SHALL : 
 
  (1) BE FOR PRESCRIPTION D RUG PRODUCTS THAT HA VE LED OR WILL 
LEAD TO AN AFFORDABI LITY CHALLENGE ; AND 
 
  (2) BE SET IN ACCORDA NCE WITH THE CRITERI A ESTABLISHED IN 
REGULATIONS ADOPTED BY THE BOARD . 
 
 (C) (1) THE BOARD SHALL : 
 
   (I) MONITOR THE AVAILABIL ITY OF ANY PRESCRIPT ION DRUG 
PRODUCT FOR WHICH IT  SETS AN UPPER PAYMEN T LIMIT ; AND 
Ch. 39  2023 LAWS OF MARYLAND   
 
– 4 –  
   (II) IF THERE BECOMES A SH ORTAGE OF THE PR ESCRIPTION 
DRUG PRODUCT IN THE STATE , RECONSIDER WHETHER T HE UPPER PAYMENT LIM IT 
SHOULD BE SUSPENDED OR ALTERED . 
 
  (2) AN UPPER PAYMENT LIMI T SET UNDER SUBSECTI ON (A) OF THIS 
SECTION MAY NOT BE A PPLIED TO A PRESCRIP TION DRUG PRODUCT WH ILE THE 
PRESCRIPTION  DRUG PRODUCT IS ON T HE FEDERAL FOOD AND DRUG 
ADMINISTRATION PRESCR IPTION DRUG SHORTAGE  LIST. 
 
21–2C–15. 
 
 (A) A PERSON AGGRIEVED BY AN UPPER PAYMENT LIMI T SET BY THE 
BOARD MAY REQUEST AN APPEAL WITHIN 30 DAYS AFTER THE BOARD  MAKES THE 
DECISION TO SET THE LIMIT . 
 
 (B) THE BOARD SHALL HEAR THE APPEAL AND MAKE A FI NAL DECISION 
WITHIN 60 DAYS AFTER THE APPEA L IS REQUESTED . 
 
 (C) ANY PERSON AGGRIEVED BY A FINAL DECISION OF THE BOARD  ISSUED 
UNDER SUBSECTION (B) OF THIS SECTION  MAY PETITION FOR JUDICIA L REVIEW AS 
PROVIDED BY THE ADMINISTRATIVE PROCEDURE ACT. 
 
21–2C–16. 
 
 ON OR BEFORE DECEMBER 1, 2026, THE BOARD , IN CONSULTATION WITH  THE 
STAKEHOLDER COUNCIL , SHALL REPORT TO THE SENATE FINANCE COMMITTEE 
AND THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE , IN 
ACCORDANCE WITH § 2–1257  OF THE STATE GOVERNMENT ARTICLE , ON: 
 
  (1) THE LEGALITY , OBSTACLES , AND BENEFITS OF SETT ING UPPER 
PAYMENT LIMITS ON AL L PURCHASES AND PAYO R REIMBURSEMENTS OF 
PRESCRIPTION DRUG PR ODUCTS IN THE STATE; AND 
 
  (2) RECOMMENDATIONS REGAR DING WHETHER THE GENERAL 
ASSEMBLY SHOULD PASS LEGISLATION TO EXPAN D THE AUTHORITY OF T HE BOARD 
TO SET UPPER PAYMENT  LIMITS TO ALL PURCHA SES AND PAYOR REIMBU RSEMENTS 
OF PRESCRIPTION DRUG  PRODUCTS IN THE STATE . 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act is an emergency 
measure, is necessary for the immediate preservation of the public health or safety, has 
been passed by a yea and nay vote supported by three –fifths of all the members elected to 
 WES MOORE, Governor  Ch. 39  
 
– 5 – each of the two H ouses of the General Assembly, and shall take effect from the date it is 
enacted.  
 
Approved by the Governor, April 11, 2023.  